Observed arrival · 2026-11-21
BioRegen’s two-device tissue-regeneration program
A Chilean biomaterials venture developing a resorbable guided-bone-regeneration membrane and a chronic-wound dressing.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Clinical partners, distributors, and pre-seed investors
- Worth noticing
- The page labels the platform TRL 4 and places in-vivo preclinical studies next, before regulatory planning and clinical partnerships.
Field notes
The membrane is described as an electrospun PLA nanofiber scaffold with nHA and bioactive glass; the page includes a confocal image captioned with MC3T3 preosteoblasts and a 50 µm scale bar. BioRegen reports laboratory and cellular validation at TRL 4, while in-vivo preclinical studies, ISP regulatory planning, and clinical partnerships remain next steps on its roadmap.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
◎NicheUnusually specific use
One card from the complete issue